Altogether, we have shown in this study that SCD1 expressed in cancer cells and immune cells such as CD8+ T cells and DCs is involved in the immune-resistant mechanisms for immune checkpoint blockade and is an attractive target for the development of new diagnostic and therapeutic strategies for effective cancer immunotherapy. This evidence concerns the gene SCD and cancer.